Release Date: 03/10/22 08:47 Summary: Annual General Meeting 30 November 2022 Price Sensitive: No Download Document 142.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%